The guidelines suggest that cystatin C-based equations be limited to use in individuals with eGFR between 45 and 59 ml/min/1.73 m2 with no other evidence of CKD [35] to verify the presence of CKD. The gene discussed is CST3; the disease is chronic kidney disease.